Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Relative Value
The Relative Value of one
Tibet Rhodiola Pharmaceutical Holding Co
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 41.74 CNY,
Tibet Rhodiola Pharmaceutical Holding Co
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Tibet Rhodiola Pharmaceutical Holding Co Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
|
13.5B CNY | 4.9 | 13.6 | 10.9 | 10.9 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
116.2B USD | 0.3 | 26.8 | 18.9 | 21.3 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
70.3B USD | 0.2 | 43.3 | 15.2 | 19.2 | |
| US |
|
Cencora Inc
NYSE:COR
|
69.8B USD | 0.2 | 43.1 | 15.1 | 19.1 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
52.8B USD | 0.2 | 31.8 | 15.3 | 19.9 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
33.8B AUD | 5.6 | 63.8 | 48.2 | 48.2 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.6B CNY | 0.2 | 11.3 | 15.2 | 15.2 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
63.1B CNY | 1.5 | 17.1 | 13.2 | 13.2 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.3B USD | 0.7 | 24 | 11.5 | 16 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
65.8B HKD | 0.1 | 8.6 | 1.6 | 2 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |